Evidence map›Paper›PMID 30669529›Full record

ArticleMedicines (Basel, Switzerland)2019

An Investigation of Potential Sources of Nutraceuticals from the Niger Delta Areas, Nigeria for Attenuating Oxidative Stress.

Lucky Legbosi Nwidu, Philip Cheriose Nzien Alikwe, Ekramy Elmorsy, Wayne Grant Carter

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicines (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. The GenusPharmaceuticals (Basel, Switzerland) · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Lucky Legbosi NwiduDepartment of Experimental Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Port Harcourt PMB 5323, Rivers State, Nigeria. menelucky@yahoo.com.ORCID 0000-0001-7328-2297
Philip Cheriose Nzien AlikweDepartment of Animal Science, Niger Delta University, Wilberforce Island, Yenegoa PMB 071, Bayelsa State, Nigeria. bushdoctor2013@gmail.com.
Ekramy ElmorsySchool of Medicine, University of Nottingham, Royal Derby Hospital Centre, Derby DE22 3DT, UK. ekramy_elmorsy@yahoo.com.
Wayne Grant CarterSchool of Medicine, University of Nottingham, Royal Derby Hospital Centre, Derby DE22 3DT, UK. wayne.carter@nottingham.ac.uk.ORCID 0000-0003-1475-2476
University of Nottingham · GBNiger Delta University · NGUniversity of Port Harcourt · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acetylcholinesterase inhibitorantioxidantsmemory enhancersnutraceuticals

Identifiers

PMID30669529
PMCPMC6473651
OpenAlexW2911094406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.